Abemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence
Technology appraisal guidance
Reference number: TA810
Published:
History
A list of downloadable documents created during development.